Gilead Sciences Receives Canadian Approval For HIV Drug
February 20, 2017 at 15:03 PM EST
Gilead Sciences Inc. announced that it has received approval in Canada for its Odefsey for treating HIV-1 infection.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.